Within the U.S., 53.3 million autoinjector combination product units were sold in 2022, with a total value of $86.7 billion
In practical terms, this means: Doses can be adjusted gradually Programs can be tailored to tolerance and response Access is often more affordable Ongoing provider oversight is central to the process This flexibility is one of the main reasons compounded semaglutide for women has gained attention in recent years
Side effects, contraindications, medication interactions, insurance rules, and long-term maintenance still matter
See our article Is IV Vitamin Therapy Safe for details on safety protocols, side effects and who should avoid treatment
BMI body mass index, CVD cardiovascular disease, HbA 1c haemoglobin A 1c , HF heart failure, MACE major adverse cardiovascular events, RCT randomised controlled trial, T2D type 2 diabetes, UACR urine albumin to creatinine ratio Implications for Practice Current clinical practice recommendations acknowledge a potential additive cardiovascular and kidney benefit from using both a GLP-1 receptor agonist and a SGLT-2 inhibitor
